Submitted by Anonymous (not verified) on 2 October 2024 - 14:48
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 5, Status: Authorised